Form 4 for CLDX Celldex Therapeutics, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001415889-24-015542 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-05 | 2024-06-03 | CLDX | Jimenez Freddy A. | SVP, GC | M - OptEx | $10.38 | +8,006 | 33.9K | +31% | +$83.1K |
| D | 2024-06-05 | 2024-06-03 | CLDX | Jimenez Freddy A. | SVP, GC | S - Sale+OE | $33.60 | -8,006 | 25.9K | -24% | -$269.0K |
| D | 2024-06-05 | 2024-06-03 | CLDX | Jimenez Freddy A. | SVP, GC | M - OptEx | $0.00 | -8,006 | 28.0K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | M | A | 8,006 | $10.38 | 33,930 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-03 | S | D | 8,006 | $33.60 | 25,924 | D | — | — | |
| 3 | Derivative | Incentive Stock Option (Right to Buy) | 2024-06-03 | M | D | 8,006 | $0.00 | 27,994 | D | $10.38 · — to 2030-06-18 | 8,006 Common Stock | (F1) 25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. |